Document is current
Any future updates will be listed below
-
Authors
Gamboa, Lena
Zamat, Ali H.
Thiveaud, Chloé A.
Lee, Hee Jun
Kulaksizoglu, Elif https://orcid.org/0009-0004-6854-2882
Zha, Zizhen
Campbell, Noah S. https://orcid.org/0009-0004-7206-7658
Chan, Ching Shen https://orcid.org/0000-0001-7794-493X
Fábrega, Sydney
Oliver, S. Abbey https://orcid.org/0009-0001-7490-4147
Su, Fang-Yi
Phuengkham, Hathaichanok
Vanover, Daryll
Peck, Hannah E.
Sivakumar, Anirudh https://orcid.org/0000-0003-0788-6476
Dahotre, Shreyas N.
Harris, Adrian M.
Santangelo, Philip J. https://orcid.org/0000-0001-7352-0339
Kwong, Gabriel A. https://orcid.org/0000-0002-6255-6755
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (DP2-HD091793, DP1-CA280832, 5T32EB006343, F31-CA271803, 5T32EB006343, F31-CA271803, 5T32GM145735)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA273878)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01EB032822)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR000454)
Shurl and Kay Curci Foundation (1S10OD016264-01A1)
Wallace H. Coulter Department of Biomedical Engineering and the College of Engineering at Peking University
National Science Foundation (DGE-1451512, DGE-1451512, DGE-1451512)
- License Information
-
More Information
Article History
Received: 19 January 2022
Accepted: 3 April 2025
First Online: 16 May 2025
Competing interests
: G.A.K. reports equity or consulting roles for Sunbird Bio, Port Therapeutics, Send Biotherapeutics and Ridge Biotechnologies. The terms of this arrangement were reviewed and approved by Georgia Tech in accordance with its conflict-of-interest policies. L.G., A.H.Z., D.V., P.J.S., C.S.C., H.J.L., C.A.T. and G.A.K. are listed as inventors on a patent application related to the results of this paper, titled ‘Synthetic Antigens as Chimeric Antigen Receptor (CAR) Ligands and Uses Thereof’ (US20230390335A1). The patent applicant is the Georgia Tech Research Corporation.
